Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation - A critical period of time is required for development of immunological unresponsiveness

被引:80
作者
Saitovitch, D [1 ]
Bushell, A [1 ]
Mabbs, DW [1 ]
Morris, PJ [1 ]
Wood, KJ [1 ]
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1097/00007890-199606150-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The combination of a depleting anti-Cd4(3) monoclonal antibody (mAb) and a single donor-specific transfusion before transplantation has been shown to induce operational transplantation tolerance in the majority of cardiac allograft recipients in a mouse model, To examine a protocol which might be more clinically relevant, we have modified this tolerance-inducing protocol by substituting the depleting with a nondepleting anti-Cd4 mAb, We show that this form of pretreatment can also induce immunologic unresponsiveness in most recipients (C3H/He, H2(k)), provided a critical period of time, in this case 28 days, is allowed between pretreatment and transplantation of a fully mismatched heart graft (H2(b)), When only 1 or 2 weeks were allowed between pretreatment and transplantation, only slight graft prolongation was obtained when compared with recipients receiving anti-Cd4 mAb alone, at these time points, Maintenance of tolerance in this model was due, at least in part, to active mechanisms as immunologic unresponsiveness to donor antigens could be transferred to naive syngeneic mice by splenocytes from recipients bearing long-term functioning grafts, These findings suggest that a population of regulatory cells develop after pretreatment with nondepleting anti-Cd4 mAb and donor-specific transfusion, and that it takes at least 1 month for these cells to expand and effectively drive the recipient's immune system toward immunologic unresponsiveness.
引用
收藏
页码:1642 / 1647
页数:6
相关论文
共 29 条
  • [1] TREATMENT OF MYASTHENIA-GRAVIS WITH ANTI-CD4 ANTIBODY - IMPROVEMENT CORRELATES TO DECREASED T-CELL AUTOREACTIVITY
    AHLBERG, R
    YI, Q
    PIRSKANEN, R
    MATELL, G
    SWERUP, C
    RIEBER, EP
    RIETHMULLER, G
    HOLM, G
    LEFVERT, AK
    [J]. NEUROLOGY, 1994, 44 (09) : 1732 - 1737
  • [2] BROSTOFF SW, 1984, J IMMUNOL, V133, P1938
  • [3] TRANSPLANTATION TOLERANCE INDUCED BY ANTIGEN PRETREATMENT AND DEPLETING ANTI-CD4 ANTIBODY DEPENDS ON CD4(+) T-CELL REGULATION DURING THE INDUCTION-PHASE OF THE RESPONSE
    BUSHELL, A
    MORRIS, PJ
    WOOD, KJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2643 - 2649
  • [4] BUSHELL AR, 1993, THESIS U OXFORD
  • [5] THE INDUCTION OF SKIN-GRAFT TOLERANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX-MISMATCHED OR PRIMED RECIPIENTS - PRIMED T-CELLS CAN BE TOLERIZED IN THE PERIPHERY WITH ANTI-CD4 AND ANTI-CD8 ANTIBODIES
    COBBOLD, SP
    MARTIN, G
    WALDMANN, H
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (12) : 2747 - 2755
  • [6] THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO
    COBBOLD, SP
    JAYASURIYA, A
    NASH, A
    PROSPERO, TD
    WALDMANN, H
    [J]. NATURE, 1984, 312 (5994) : 548 - 551
  • [7] PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE - ROLE OF H-2D, H-2K, AND NON-H-2 ANTIGENS IN REJECTION
    CORRY, RJ
    WINN, HJ
    RUSSELL, PS
    [J]. TRANSPLANTATION, 1973, 16 (04) : 343 - 350
  • [8] DALLMAN MJ, 1982, TRANSPLANTATION, V33, P221
  • [9] EVIDENCE THAT LONG-TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI-CD4 MONOCLONAL-ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T-CELLS
    DARBY, CR
    MORRIS, PJ
    WOOD, KJ
    [J]. TRANSPLANTATION, 1992, 54 (03) : 483 - 490
  • [10] NONDEPLETING ANTI-CD4 ANTIBODIES IN TRANSPLANTATION - EVIDENCE THAT MODULATION IS FAR LESS EFFECTIVE THAN PROLONGED CD4 BLOCKADE
    DARBY, CR
    BUSHELL, A
    MORRIS, PJ
    WOOD, KJ
    [J]. TRANSPLANTATION, 1994, 57 (10) : 1419 - 1426